• No results found

Molecular genetic studies on Chronic Lymphocytic Leukemia & Acute Myeloid Leukemia

N/A
N/A
Protected

Academic year: 2021

Share "Molecular genetic studies on Chronic Lymphocytic Leukemia & Acute Myeloid Leukemia"

Copied!
1
0
0

Loading.... (view fulltext now)

Full text

(1)

Molecular genetic studies on

Chronic Lymphocytic Leukemia

& Acute Myeloid Leukemia

-with focus on prognostic markers

Kerstin Willander

Linköping University Medical Dissertations No. 1393

Linköping University Medical Dissertations No. 1393, 2014 Division of Cell Biology

Department of Clinical and Experimental Medicine Faculty of Health Sciences

Linköping University 581 85 Linköping, Sweden

www.liu.se

Kerstin Willander

Molecular genetic studies on Chronic L

ymphocytic Leukemia & Acute Myeloid Leukemia

References

Related documents

Multivariate analysis of TFS including the high- risk parameters (short telomeres, Binet stage B/C, CD38 and ZAP70 positivity, unmutated IGHV genes and

Increased prevalence of prior malignancies and autoimmune diseases in patients diagnosed with chronic myeloid leukemia.. Second malignancies following treatment of

For paper I the Swedish cancer register (SCR) was used to identify all Swedish CML patients since 1970 and the Swedish cause of death register to identify an eventual

DCs are antigen presenting cells (APCs) which in contrast to other APCs (B cells, macrophages) are able to activate T cells. DCs have four functions that contribute to T

The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL). Annals of

The primary aim of the present thesis was to investigate the influence of CYP3A metabolic activity and cellular transport mediated by genetic variants of ABCB1 and ABCG2

In paper I, we screened a population-based cohort of CLL patients (n=364) for TP53, NOTCH1, SF3B1, BIRC3 and MYD88 mutations using Sanger sequencing, and confirmed

AKN-028 is a potent inhibitor of FLT3 with an IC 50 value of 6 nM in an enzyme assay, but also displaying in vitro activity in a variety of primary AML samples, irrespective of